NeuroSense Therapeutics Ltd. , a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases.
Neurosense Therapeutics stock last closed at $1.12, up 8.21% from the previous day, and has decreased 10.4% in one year. It has overperformed other stocks in the Biotechnology industry by 0.1 percentage points. Neurosense Therapeutics stock is currently +40% from its 52-week low of $0.80, and -56.92% from its 52-week high of $2.60.
As of Oct 31, 2025, there are 24.6M shares of NRSN outstanding. The market value of NRSN is $27.55M. In the past 24 hours, 150,000 NRSN shares were traded.
You need a brokerage account to access the NASDAQ market and buy NRSN stock.
Based on our experience, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you need to fill out some personal information so you are able to invest in NRSN today.
Now that you have filled out your info on the best stock app, your next step is to transfer the money for your investment:
Check out the video below for more details transferring funds into your brokerage account.
After you have chosen the best place to buy Neurosense Therapeutics stock, it's very important to evaluate their stock before you invest, so you can comprehend the risk and opportunity.
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis in less time.
You can see all of the due diligence checks on NRSN's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NRSN's fair value.
You can do additional valuation research on NRSN's stock here.
Out of 1 sell side analysts who monitor NRSN, the consensus analyst rating on NRSN is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Neurosense Therapeutics stock forecast page.
Over the last 12 months, executives and large shareholders at NRSN have not bought or sold any shares.
Learn more about who owns NRSN shares here.
No, Neurosense Therapeutics doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two main options:
Press the Open Trade button and your broker will execute your order.
If you want more help with investing in stocks on eToro, click the how to video below:
Now that you own some NRSN shares, you'll want to keep up with your company.
Start a watchlist to get alerted to the latest events about your NRSN stock.
To reiterate, here are the 6 steps to buy Neurosense Therapeutics stock:
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to watch your new investment in Neurosense Therapeutics, create a watchlist today.